What is Symprotek?
Symprotek Corporation operates as a critical node in the electronics manufacturing ecosystem, providing comprehensive turnkey PCB assembly services. The company distinguishes itself through a robust regulatory framework, maintaining ITAR and FDA registrations alongside ISO 13485 certification, which is essential for high-stakes medical device production. Beyond core manufacturing, Symprotek offers end-to-end lifecycle management, including design engineering and warranty support. By catering to small and mid-tier enterprises, the firm effectively bridges the gap between prototype development and high-volume production, utilizing economies of scale to drive significant cost efficiencies for its client base.
How much funding has Symprotek raised?
Symprotek has raised a total of $740K across 2 funding rounds:
Debt
$350K
Debt
$390K
Debt (2020): $350K with participation from PPP
Debt (2021): $390K led by PPP
Key Investors in Symprotek
PPP
Public-Private Partnership
What's next for Symprotek?
With the recent influx of capital, Symprotek is positioned to accelerate its operational footprint and enhance its manufacturing throughput. The strategic focus will likely shift toward optimizing supply chain resilience and expanding its service portfolio to accommodate the growing demand for specialized electronic components. As the company matures, the integration of advanced manufacturing technologies and the potential for further market penetration in the medical and defense sectors remain key growth drivers. Investors are closely monitoring how the firm utilizes this liquidity to navigate the complexities of global logistics while maintaining the stringent quality standards required by its regulatory certifications.
See full Symprotek company page
